Skip to main content
All lobbying filings

THE GIBSON GROUP, LLC

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES · National trade organization representing the interests of generic drug manufacturers.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Oct 13, 2025

Official filing document

 Bills named in this filing 2
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1040
    Drug Competition Enhancement Act
 Lobbying activity 4
Health Issues

Drug competition issues Monitor drug supply chain issues

Labor Issues/Antitrust/Workplace

Drug competition issues

Copyright/Patent/Trademark

Monitor S 1096 - patent settlements Monitor issues relating to review of pharmaceutical patents in inter partes reviews Monitor issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act

Trade (domestic/foreign)

Monitor issues related to trade agreeements

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem